The Patent Finder

Histone Demethylase Inhibitors

Celgene Corporation

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 8 of these applications claim priority to application 62/051,691, filed Sep 17, 2014. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 9,643,965Histone Demethylase Inhibitors
In force
 · High confidence
Celgene Quanticel Research, Inc.In force
High confidence
US 10,112,940Histone Demethylase Inhibitors
Grace period ended Oct 30, 2026 · lapse expected
 · Low confidence
Celgene Quanticel Research, Inc.Grace period ended Oct 30, 2026
lapse expected
Low confidence
US 10,202,381Histone Demethylase Inhibitors
In force
 · Medium confidence
Celgene Quanticel Research, Inc.In force
Medium confidence
US 10,208,039Histone Demethylase Inhibitors
In force
 · Medium confidence
Celgene Quanticel Research, Inc.In force
Medium confidence
US 10,611,763Histone Demethylase Inhibitors
In force
 · High confidence
Celgene Quanticel Research, Inc.In force
High confidence
US 10,815,234Histone Demethylase Inhibitors
In force
 · High confidence
Celgene Quanticel Research, Inc.In force
High confidence
US 12,172,998Histone Demethylase Inhibitors
In force
 · High confidence
Celgene Quanticel Research, Inc.In force
High confidence
US 11,535,616Histone Demethylase Inhibitors
In force
 · High confidence
Celgene Quanticel Research, Inc.In force
High confidence
Application 18/935,237Histone Demethylase Inhibitors
Pending
Not granted
Celgene Quanticel Research, Inc.PendingNot granted
9 of 9 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
8 of these are in force and held by Celgene Corporation.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited